Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy.

Camzyos (mavacamten) - BMS

Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy. (PubMed, Eur Cardiol) - Sep 16, 2026 - No abstract available
Journal • Review • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Non-obstructive Hypertrophic Cardiomyopathy

http://www.ncbi.nlm.nih.gov/pubmed/42741230

Aditi Mohta; Akshyaya Pradhan; Bhushan Shah; Sudesh Prajapathi

Sep 16, 2026